Patents by Inventor Jennifer L. Edwards

Jennifer L. Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210338685
    Abstract: The present disclosure relates to the use of ligands of complement receptor 3, including ligands of the I domain of the alpha subunit of this receptor, in methods, compositions and articles/devices for inhibiting the interaction of pathogens to a complement receptor 3-expressing cell and for treating or inhibiting the development of infections caused by such pathogens.
    Type: Application
    Filed: September 30, 2019
    Publication date: November 4, 2021
    Inventors: Michael P. JENNINGS, Jennifer L. EDWARDS, Christopher J. DAY, Johnson MAK
  • Patent number: 7261901
    Abstract: The present invention is directed to novel polypeptides, polynucleotides and vaccines for use against Neisseria gonorrhoeae colonization or infection and/or Neisseria meningitidis colonization or infection. The vaccines contain an immunogenic amount of a neisserial protein.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: August 28, 2007
    Assignee: University of Iowa Research Foundation
    Inventors: Michael A. Apicella, Jennifer L. Edwards
  • Patent number: 7250172
    Abstract: The present invention is directed to novel polypeptides, polynucleotides and vaccines for use against Neisseria gonorrhoeae colonization or infection. The vaccines contain an immunogenic amount of a neisserial protein.
    Type: Grant
    Filed: January 31, 2002
    Date of Patent: July 31, 2007
    Assignee: University of Iowa Research Foundation
    Inventors: Michael A. Apicella, Jennifer L. Edwards, Bradford W. Gibson, Karoline Scheffler
  • Publication number: 20040253222
    Abstract: The present invention is directed to novel polypeptides, polynucleotides and vaccines for use against Neisseria gonorrhoeae colonization or infection and/or Neisseria meningitidis colonization or infection. The vaccines contain an immunogenic amount of a neisserial protein.
    Type: Application
    Filed: September 19, 2003
    Publication date: December 16, 2004
    Inventors: Michael A. Apicella, Jennifer L. Edwards
  • Publication number: 20030100071
    Abstract: The present invention is directed to novel polypeptides, polynucleotides and vaccines for use against Neisseria gonorrhoeae colonization or infection. The vaccines contain an immunogenic amount of a neisserial protein.
    Type: Application
    Filed: January 31, 2002
    Publication date: May 29, 2003
    Inventors: Michael A. Apicella, Jennifer L. Edwards, Bradford W. Gibson, Karoline Scheffler, Eric Brown